Cleveland, OH, United States of America

Ritika Jaini

This inventor holds 5 USPTO granted patents and 1 published patent application. Top assignee: The Cleveland Clinic Foundation. Active years: 2015-2025.

USPTO Granted Patents = 5 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2015-2025

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Ritika Jaini: Innovator in Breast Cancer Vaccine Development

Introduction

Ritika Jaini is a prominent inventor based in Cleveland, OH (US). She has made significant contributions to the field of immunology, particularly in the development of vaccines for breast cancer. With a total of 5 patents to her name, Jaini is recognized for her innovative approaches to combating this serious disease.

Latest Patents

Among her latest patents, Jaini has developed compositions and methods for immunization against human breast cancer. One of her notable inventions includes a breast cancer vaccine that comprises an immunogenic polypeptide derived from human α-lactalbumin. This groundbreaking work aims to provide new avenues for breast cancer treatment and prevention.

Career Highlights

Ritika Jaini is affiliated with The Cleveland Clinic Foundation, where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science and improving patient outcomes. Jaini's innovative spirit and dedication to her field have positioned her as a leader in breast cancer research.

Collaborations

Throughout her career, Jaini has collaborated with esteemed colleagues, including Vincent K. Tuohy and Justin M. Johnson. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in cancer treatment.

Conclusion

Ritika Jaini's contributions to breast cancer vaccine development exemplify her dedication to innovation in medical science. Her work not only highlights her expertise but also offers hope for improved treatments for breast cancer patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…